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INTRODUCTION
The lipid composition of membranes has been suggested as a major
factor in determining the metabolic rate of animals. This idea
constitutes the Membrane Pacemaker Theory of Metabolism. This
theory proposes that membrane lipids influence the rate of turnover
of membrane bound proteins (i.e. molecular or molar activity, this
is the rate of substrate turnover per protein molecule) including those
that produce and use the energy of metabolism (Hulbert and Else,
1999; Hulbert and Else, 2000). This theory is based on measurements
showing predictable systematic changes in membrane phospholipid
acyl composition in tissues from animals with different metabolic
rates (Hulbert et al., 2002a; Turner et al., 2003) plus experiments
demonstrating changes in the rate of turnover of membrane enzymes
associated with lipid composition and following species membrane
cross-over experiments (Else and Wu, 1999; Wu et al., 2001; Wu
et al., 2004).
The measurement of membrane phospholipid acyl composition
in these previous experiments has been conducted using gas
chromatography following hydrolysis of fatty acids from their
glycerol backbone. This utilitarian method has one major
disadvantage; it cannot identify the phospholipid class(es) within
which this variation occurs. To gain this information requires a
multidimensional chromatography approach that can reduce the
sensitivity and reliability of the measurement. An alternative method
for analysis of intact phospholipids is electrospray ionisation tandem
mass spectrometry. The appeal of mass spectrometry is its ability
to provide accurate, reliable, unambiguous identification and
quantification of intact phospholipid molecules with high sensitivity
(Ekroos et al., 2002; Han and Gross, 2003; Han and Gross, 2005;
Pulfer and Murphy, 2003).
Recently we applied this new approach to examine the membrane
lipids of a mammal (the rat, Rattus norvegicus) and a reptile (a lizard,
Trachydosaurus rugosus) of similar body mass and preferred body
temperature. The study (Mitchell et al., 2007) examined the
molecular sources of the lower unsaturation index (the number of
double bonds per 100 acyl chains), higher monounsaturation and
lower polyunsaturation of membrane phospholipids previously
described in ectothermic compared with endothermic vertebrates
(Hulbert and Else, 1989). The study (Mitchell et al., 2007) found
that all phospholipid classes contribute to the differences in acyl
composition of membrane phospholipids and that the distribution
of phospholipid classes within the same tissues of the mammal and
reptile were essentially the same.
In this present study we used a similar method to examine the
phospholipids responsible for the systematic differences in acyl
composition reported for mammals of different body size (Hulbert
et al., 2002b). These differences include decreases in the
unsaturation index and decreases in the omega-3 (n-3)
polyunsaturated fat content (particularly docosahexaenoic acid
22:6n-3) with increasing body mass in mammals. Kidney and brain
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SUMMARY
The acyl composition of membrane phospholipids in kidney and brain of mammals of different body mass was examined. It was
hypothesized that reduction in unsaturation index (number of double bonds per 100 acyl chains) of membrane phospholipids with
increasing body mass in mammals would be made-up of similar changes in acyl composition across all phospholipid classes and
that phospholipid class distribution would be regulated and similar in the same tissues of the different-sized mammals. The
results of this study supported both hypotheses. Differences in membrane phospholipid acyl composition (i.e. decreased omega-
3 fats, increased monounsaturated fats and decreased unsaturation index with increasing body size) were not restricted to any
specific phospholipid molecule or to any specific phospholipid class but were observed in all phospholipid classes. With increase
in body mass of mammals both monounsaturates and use of less unsaturated polyunsaturates increases at the expense of the
long-chain highly unsaturated omega-3 and omega-6 polyunsaturates, producing decreases in membrane unsaturation. The
distribution of membrane phospholipid classes was essentially the same in the different-sized mammals with phosphatidylcholine
(PC) and phosphatidylethanolamine (PE) together constituting ~91% and ~88% of all phospholipids in kidney and brain,
respectively. The lack of sphingomyelin in the mouse tissues and higher levels in larger mammals suggests an increased
presence of membrane lipid rafts in larger mammals. The results of this study support the proposal that the physical properties
of membranes are likely to be involved in changing metabolic rate.
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were chosen as the tissues for examination based on their apparent
differences in mammals (Hulbert et al., 2002b). In kidney,
membrane acyl composition has been found to vary with variation
in body size, in line with that found in other tissues (e.g. liver,
heart and skeletal muscle) and its dominant polyunsaturated fats
are omega-6 (n-6) fats. By contrast, the brain does not show these
large-scale changes in membrane acyl composition with changes
in body mass, and its dominant polyunsaturated fats are omega-
3 fats (Hulbert et al., 2002b).
Species selection for this study was based on those mammals
most commonly used in body size (allometric) analysis and ready
availability. It should be noted that because of the large volume of
work involved in these measurements we were forced to limit our
species selection to three mammal species only (i.e. mouse, sheep
and cow). The previous results for the rat were not included since
although similar, the methods employed were subtly different and
so did not allow for reliable quantitative comparison. Furthermore,
it should be noted that this study is not an allometric study nor has
it the capacity to avoid some phylogenetic bias based on the number
of species used. The animals used in the current study have already
been shown to reflect the average membrane phospholipid acyl
composition for body mass in mammals (Hulbert et al., 2002b).
This study focuses on examining membrane phospholipid molecules
in precise detail in three different-sized mammal species against the
differences in acyl composition already well established for
mammals and well represented by the mammals chosen for inclusion
in this study (Hulbert et al., 2002b).
Based on our study of an ectotherm and endotherm, we
hypothesized that the same rules would apply to differences in
phospholipid acyl composition in mammals of varying body mass.
We proposed that changes in acyl composition such as the reduction
in unsaturation index and decrease in the more highly unsaturated
omega-3 and omega-6 fats with increase in mass in mammals will
be spread throughout all phospholipid classes and that phospholipid
head group (i.e. class) will be regulated and similar in the different-
sized mammals.
MATERIALS AND METHODS
Materials
All solvents used were HPLC grade and purchased from Crown
Scientific (Moorebank, NSW, Australia). Analytical grade butylated
hydroxytoluene (BHT) was purchased from Sigma Aldrich (Castle
Hill, NSW, Australia). Phospholipid standards were synthesised by
Avanti Polar Lipids (Alabaster, AL, USA) and purchased from
Auspep (Parkville, Victoria, Australia).
Animals, organs and ethics
Sheep (Ovis aries L.; body mass ~38kg) and cattle (Bos taurus L.;
herein referred to as cow, body mass ~560kg) kidney and brains
were collected from the Wollondilly Abattoir (Picton, NSW,
Australia) immediately following the death of each animal. Organs
were transported on ice then stored at –80°C until used. Body masses
for the sheep and cattle were determined from their individual
carcass mass (i.e. that of slaughtered animal minus hide, head, tail,
extremities and viscera) assumed to be 55% of body mass (as
determined and used commercially at the abattoir). Male C57bl/6
mice (Mus musculus Linnaeus; body mass ~30g) were obtained from
the Animal Resource Centre (Perth, WA, Australia), kept under
standard 12h:12h light:dark conditions and sacrificed by peritoneal
injection of sodium pentobarbitone at a concentration of
0.6mgg–1 bodymass. The kidney and brains were collected from
four individuals of the three animal species studied and stored at
–80°C until used. The University of Wollongong Animal Ethics
Committee approved all animal-based experimentation.
Lipid extraction
Samples of brain and kidney were homogenised (at 0.25gml–1) in
glass–glass tissue homogenisers in 2:1 chloroform:methanol
containing 0.01% butylated hydroxytoluene and 4 μlmg–1 tissue
of a stock solution of phospholipid internal standards
[phosphatidylcholine (PC) 19:0/19:0, 250 μmol l–1;
phosphatidylethanolamine (PE) 17:0/17:0, 188 μmol l–1;
phosphatidylserine (PS) 17:0/17:0, 125 μmol l–1; phosphatidic acid
(PA) 17:0/17:0, 25 μmol l–1; and phosphatidylglycerol (PG)
17:0/17:0, 25 μmol l–1, in methanol:chloroform) was added. Total
lipid extracts were then place on a rotating platform that turned the
samples upside down overnight in order to maximise lipid extraction.
This was followed by an acid wash (1mol l–1 H2SO4) to further
enhance extraction of acidic phospholipids and standard procedures
followed thereafter as previously described (Folch et al., 1957). All
extracts were stored at –80°C until analysed.
Mass spectrometry
Electrospray ionisation mass spectrometry (ESI–MS) analysis was
performed on a Waters QuattroMicroTM (Waters, Manchester, UK)
equipped with a z-spray electrospray ion source and controlled by
Micromass Masslynx version 4.0 software. Capillary voltage was
set to 3000V, source temperature 80°C and desolvation temperature
120°C. Cone voltage was set to 50V and –35V in negative and
positive ion mode, respectively. Nitrogen was used as the drying
gas at a flow rate of 320 lh–1. Phospholipid extracts were diluted to
an estimated final concentration of 40 μmol l–1 with the addition of
methanol:chloroform (2:1v:v). For negative ion analyses, ammonia
(28%) was added to adjust the pH to 10. Samples were infused into
the electrospray ion source at a flow rate of 10 μlmin–1 using the
instrument’s on-board syringe pump. In all precursor ion, neutral
loss and product ion scans, argon was used as the collision gas at
a pressure of 3mTorr and the collision energy was set between
22–50eV depending upon on the scan being performed. Phosphatidic
acid (PA), phosphatidylglycerol (PG), phosphatidylinositol (PI),
phosphatidylethanolamine (PE) and phosphatidylserine (PS)
phospholipids readily form [M–H]– anions in negative ion mode
and were detected in the mass range of m/z640–940. By contrast
phosphatidylcholine (PC) and sphingomyelin (SM) phospholipids
were detected as [M+H]+ ions in positive ion mode at m/z640–850
(Brugger et al., 1997). PE and PS phospholipids also formed
abundant [M+H]+ ions in positive ion mode that were used here for
quantification of these two classes. Overall a combination of
precursor ion and neutral loss scans in both positive and negative
ion modes were used to identify the head-group of each phospholipid
as previously described. For phospholipid classes observed in
negative ion mode, precursor ion scans of the fatty acid carboxylate
anions in negative ion mode allowed for the identification of fatty
acids associated with each individual phospholipid. To allow for
the identification of the acyl chains in PC phospholipids, neutral
loss scans for loss of the lithiated fatty acids were performed in
positive ion mode after aqueous lithium acetate was added to the
lipid extract (to a final concentration of 200 μmol l–1 in
methanol:chloroform 2:1; v:v). A full description of all scans types
performed in this study and corresponding instrumental parameters
is provided in Table S1 in supplementary material. Where two or
more isomeric phospholipids of the same class were identified (e.g.
PE18:1/18:1 and PE18:0/18:2) a product ion spectrum was obtained.
The abundances of the pairs of fatty acid carboxylate anions arising
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from each isomer in this spectrum were summed and normalized
to the abundance of all fatty acid carboxylate anions to obtain the
relative contribution of all isomers to the abundance of the parent
ion (e.g. the contribution of PE18:0/18:2 to the precursor ion at m/z
742 is given by the correction factor [I283+I279]/[I283+I279+I281],
where I283, I281 and I279 are the intensities of the 18:0, 18:1 and 18:2
fatty acid carboxylate anions, respectively, in the product ion
spectrum of m/z 742 in negative ion mode). It should be noted that
neither the relative position of the acyl chains on the glycerol
backbone (sometimes called the sn-position) (Ekroos et al., 2003)
nor the position of double bonds (Thomas et al., 2007) can be
rigorously assigned from these data and discussions in this paper
are based on naturally abundant regioisomers.
For quantification purposes, head-group-specific neutral loss
and precursor ion mass spectra (see Table S1 in supplementary
material) were obtained from averaging a minimum of 200 scans.
Phospholipids were quantified by comparing their peak areas with
the peak area of an appropriate internal standard for each
phospholipid class following corrections for isotope contributions
as described by Han and Gross (Han and Gross, 2005). Briefly,
the increasing natural abundance of 13C-isotope ions with
increasing carbon chain length distributes the ion abundance from
a single phospholipid toward isotopologues of higher mass. For
accurate quantification, the contributions of all isotopologues were
summed to provide a single, comparable measure of abundance
for each lipid; independent of size. To achieve this, the isotopic
ion distribution of each phospholipid was calculated from isotope
models and the area of the monoisotopic peak was multiplied by
the calculated correction factor. For example, the calculated
isotopic abundances for PE 18:2/18:2 are M=1.0, M+1=0.475,
M+2=0.126 and M+3=0.024 and thus for quantification, the
abundance of the monoisotopic ion is corrected by a factor of 1.63.
Conversely, the contribution of phospholipid isotopologues to the
area of the monoisotopic peak of a lipid of higher m/z needs to
be subtracted for accurate quantification. Isotopic corrections of
this type were carried out sequentially from low to high m/z such
that any contribution of isotopologues from low mass lipids were
subtracted from phospholipids of greater m/z, prior to isotopic
correction of the abundance of the heavier ion (as above). For
example, if both PE 18:2/18:2 and PE 18:1/18:2 were found to be
present in a positive ion mass spectrum, the abundance of the latter
lipid (APE 18:1/18:2) was obtained from the corrected intensity of the
peak at m/z 742 (I742) via APE 18:1/18:2=I742–0.126APE 18:2/18:2,
where APE 18:2/18:2 is the already corrected abundance of PE
18:2/18:2.
As no appropriate internal standards for SM or PI where available,
their concentrations where derived from internal standards from
related lipid classes. Specifically, sphingomyelins were quantified
by comparison with the PC internal standard and multiplication by
a correction factor of 3.15 that takes into account the underestimation
of SM abundance in precursor ion scans of m/z184 due to the
differing fragmentation efficiency of these two choline-bearing lipid
classes. The correction factor was determined by comparison of
signal response of SM 16:0 and SM 18:1 with PC 16:0/18:1 and
PC 18:1/18:1 in m/z 184 precursor ion scans over a concentration
range of 0.8–1.6 μmol l–1. An approximate quantification of PI was
achieved via comparison of the most abundant phosphatidylinositol,
PI 18:0/20:4, to the mean abundance of PA and PG internal standards
in a negative ion mass spectrum. This empirical correction for
relative ionization efficiencies is derived from Koivusalo et al.
(Koivusalo et al., 2001). The relative abundance of other PIs were
then derived by comparison with PI 18:0/20:4 in an m/z 241
precursor ion scan undertaken in negative ion mode. Given the
approximations associated with the quantification of both SM and
PI, these data are treated separately to those of other phospholipid
classes in the following discussion.
Statistical analysis
Data were analysed by a one-way ANOVA using species as a fixed
factor, with a Student’s t-test for comparison of means. For unequal
variances, a Welch one-way ANOVA was undertaken. Normality
of data was assumed from previous GC studies (Hulbert et al.,
2002b). P values of <0.05 were considered statistically significant,
and all values are expressed as means ± s.e.m. Statistical analyses
were completed using JMP 5.1 (SAS Institute, NC, USA).
RESULTS
Phospholipid class distribution and sphingomyelin
concentration
The concentration and distribution of the six different
glycerophospholipid classes (PC, PE, PS, PA, PG and PI) and SM
were measured in kidney and brain of mouse, sheep and cow. The
relative distribution of these phospholipids is shown in Table 1.
A relatively similar distribution within each tissue in each of the
mammals is apparent. PC was the major glycerophospholipids in
kidney and brain (71% and 68%, respectively), PE the second
(19–20%) and PS the third (5–7% in kidney and 10% in brain)
most abundant glycerophospholipid. PA was present, but at low
levels (1.3–2.5%) and PG was detected but at very low levels (less
than 0.4%). PI concentration was negligible (the highest value
found was in kidney at approximately 0.14 μmol g–1). No PI was
found in mouse kidney whereas in sheep and cow 44 and 42%,
respectively, were PI 18:0/20:4. The second most abundant PI
molecule was 18:0/20:3 at 9 and 13% in sheep and cow kidney,
respectively. In brain the dominant PI molecules was PI 18:0/20:4
representing 74, 66 and 67% of all PIs in mouse, sheep and cow,
Table1. Class distribution of glycerophospholipids in kidney and
brain of mouse, sheep and cow
Glycerophospholipid Mouse Sheep Cow
Kidney 
PC (%) 72.5±0.9c 72.1±0.4c 68.4±1.6m,s
PE (%) 19.6±0.5c 18.0±0.5c 23.5±0.9m,s
PS (%) 5.4±0.2s 7.4±0.2m 6.3±0.9
PA (%) 2.5±0.3 2.1±0.1 1.7±0.4
PG (%) ND 0.4±0.2 0.2±0.1
SM (μmol g–1 tissue) ND 5.98±0.63 5.9±0.8
Brain 
PC (%) 66.7±2.4 69.4±0.7 69.3±0.9
PE (%) 21.6±2.8 18.1±1.6 18.2±1.0
PS (%) 10.2±2.6 10.8±1.4 10.5±0.3
PA (%) 1.3±0.1 1.6±0.2 2.0±0.3
PG (%) 0.2±0.1 0.2±0.1 0.1±0.1
SM (μmol g–1 tissue) ND 4.0±0.9c 9.3±1.8s
PC, phosphatidylcholine; PE, phosphatidylethanolamine:
PS, phosphatidylserine; PA, phosphatidic acid; PG, phosphatidylglycerol;
SM, sphingomyelin. 
Total glycerophospholipid concentrations (PC, PE, PS, PA) in mouse, sheep
and cow kidney were 34.7, 32.8 and 40.7 μmol g–1 tissue, and for brain
were 74.7, 96.7 and 101.3 μmol g–1 tissue. Phosphatidylinositol
concentration was negligible.
Values are mean ± s.e.m. (N=4). ND, not detected. Superscript letters
indicate significant differences between species at P<0.05: m, mouse;
s, sheep; c, cow. 
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respectively. SM concentration in kidney varied from being
undetectable in the mouse to about 6 μmol g–1 in sheep and cow
kidney (this equals 18 and 14 SM molecules per 100
glycerophospholipid molecules in the sheep and cow kidney). In
brain, SM concentration appeared to increase with body mass,
being undetectable in the mouse but at 4.0 and 9.3 μmol g–1 (4 and
9 SM molecules per 100 glycerophospholipid molecules) in the
brain of the sheep and cow, respectively.
Phospholipid molecules
Kidney
The distribution of phospholipid molecules belonging
to the three most abundant classes, PC, PE and PS,
in kidney and brain are provided in Fig. 1 (kidney)
and Fig. 2 (brain). Statistical analysis of the results is
presented in Table 2. Comparing the species, the
kidney displayed a large number of differences
whereas the brain showed relatively few. The diversity
of phospholipid molecules was far greater in the
kidney (82–120 different molecular combinations
detected) compared with the brain (64–66 different
combinations, i.e. including all PC, PE, PS, PA, PG,
PI, SM). The two PC molecules with the highest
concentration in kidney were PC 16:0/18:1 and
PC 16:0/18:2 in sheep and cow, whereas in the mouse
the PC with the highest concentration was
PC 16:0/16:0 (followed by 16:0/18:1, 16:0/18:2,
16:0/20:4, 16:0/22:6, 18:0/20:4, at similar levels).
This difference emphasises the lower levels of
monounsaturated and less unsaturated
polyunsaturated fats and higher levels of highly
polyunsaturated fats in the membrane of the smallest
mammal studied. In all three animals examined, the
major PC phospholipid molecules associated with
kidney are dominated by molecular combinations
involving 16:0 (72, 61 and 83% of all PC molecules
contained 16:0 in mouse, sheep and cow,
respectively).
Among kidney PE phospholipids, the molecule
with the highest concentration in all three mammalian
species was PE 18:0/20:4. The only other PE
molecule present in moderately high abundance (in
all three species) was PE 18:1/20.4. The PS
phospholipids in highest concentration in both the
mouse and sheep was PS 18:0/20:4, whereas in the
cow PS 18:0/18:2 was most abundant, followed by
PS 18:0/20:4. Among the other phospholipid classes
there were no common trends with the most common
PA molecule being PA 18:0/20:4 in the mouse,
PA 16:0/18:1 in the sheep and PA 16:0/18:2 in the
cow. In mouse kidney, 24 different molecular
combinations of PA were detected whereas the
variety of PA molecules in the sheep and cow was
almost half that amount (11 and 14 PA molecules, respectively).
This probably reflects a higher and therefore more detectable level
of PA molecules in the mouse kidney. For PG the only detectable
molecule was PG 16:0/18:1 and this was only found in sheep and
cow kidney. SMs were not detected in the mouse kidney but were
detected in both the sheep and cow kidney with the same nine
SM combinations found: SM 16:0 was found at several times
higher concentration (2.7 and 2.1 μmol g–1 tissue) than other SMs.
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Mouse Sheep CowA
Mouse SheepB
Mouse SheepC
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Fig. 1. A comparison of the type and concentration of the
three most common glycerophospholipid classes (A)
phosphatidylcholine (PC), (B) phosphatidylethanolamine (PE)
and (C) phosphatidylserine (PS) present in mouse, sheep
and cow kidney. Statistical analysis for differences in the
concentration of these phospholipids in kidney between the
three mammal species is provided in Table 2. Values are
means ± s.e.m. (N=4).
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Of the SMs present in both the sheep and cow kidney, 80–85%
contained a saturated fatty acid (mainly 16:0 or 22:0).
Brain
PC16:0/18:1 constituting 24, 31 and 32% of all glycero phospho -
lipids in the brains of the mouse, sheep and cow, respectively, must
be considered as the primary ‘house keeping’ phospholipid of the
brain, being at levels two to four times higher than the next most
abundant PC molecule (PC 16:0/16:0). Most PC
phospholipid molecules in the brain were partnered with
16:0 (80–82%, as also found for kidney). Among the
18:0-containing PC phospholipids, 18:0/18:1, 18:0/20:4
and 18:0/22:6 were present in relatively high abundance
in all three mammals. The high level of PC18:0/18:1 in
the brain was a property not shared by the kidney. Other
interesting PC phospholipids present in higher
concentrations in the brain of all three mammals were
16:0/22:6 and 16:0/20:4 that shared similar levels in the
brain (~2.4–5% of PC molecules).
Among brain PE molecules, PE18:0/22:6 was the
most abundant being 2–5 times more concentrated than
the next most abundant molecules PE18:0/20:4 and
PE16:0/22:6. PE molecules were highly polyunsaturated
(80–87% of molecules). Although PE molecules
represented only 18–21% of brain glycerophospholipids
they served as the major source of polyunsaturated fats
raising the unsaturation index (i.e. the number of double
bonds per 100 acyl chains) from 83, 76 and 68 without
PE to 144, 138 and 128 with PE in mouse, sheep and
cow brain, respectively. PS18:0/22:6 was the most
common phosphatidylserine molecule and the major
contributor to membrane docosahexaenoic acid (DHA)
concentration. Among PA and PG molecules,
PA 18:0/22:6 and PG 16:0/18:1 were the best
represented, being present in all three animal species at
low levels.
Contribution of individual glycerophospholipid
molecules and phospholipid classes to the
unsaturation index 
The glycerophospholipids that contributed most to the
unsaturation index (UI) of the kidney were PC16:0/22:6
(27.0) in mouse and PC16:0/18:2 (9.8 and 19.7) in the
sheep and cow (see Table2). Owing to the higher UI in
the mouse kidney, other major contributors to UI in this
species included PC16:0/20:4 (19.4), PE18:0/20:4 (16.2)
and PC18:0/20:4 (15.1) all contributing more than 15
UI units. In sheep and cow kidneys the only other
phospholipid that contributed significantly to the UI was
PE18:0/20:4 (at 9.6 and 10.2, respectively). In the brain
the major contributors to UI were PE 18:0/22:6,
PS18:0/22.6, PC16:0/18:1 and PC16:0/22:6, in all three
species.
Tables 3 and 4 compare the contributions of the four major
phospholipid classes (PC, PE, PS and PA) to the UI of the kidney
and brain of mouse, sheep and cow. The tables also show the
contributions to UI of the primary unsaturated acyl chains (18:1n-
9, 18:2n-6, 20:4n-6 and 22:6n-3) plus the sum of saturated,
monounsaturated, omega-3 and omega-6 polyunsaturated fats
within each class of phospholipid in the kidney and the brain of
the three mammals. For kidney, UI decreases as body mass
Mouse Sheep CowA
Mouse SheepB
Mouse SheepC
0 5000 10,000 15,000 20,000 25,000 30,000 35,000 40,000
0 1000 2000 3000 4000 5000 6000 7000 8000 9000
Amount (nmol g–1 tissue wet mass)
PC
PE
PS
0 1000 2000 3000 4000 5000 6000 7000
Fig. 2. A comparison of the type and concentration of the three
most common glycerophospholipid classes (A)
phosphatidylcholine (PC), (B) phosphatidylethanolamine (PE)
and (C) phosphatidylserine (PS) present in mouse, sheep and
cow brain. Statistical analysis for the differences in the
concentration of these phospholipids in brain between the
three mammal species is provided in Table 2. Values are
means ± s.e.m. (N=4).
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increases in all four classes of phospholipid (Table 3). In the brain
the decrease in UI with increasing body mass only holds for PC
and the change is small (but significant, because of the very low
variance present in the values; see Table 4). In kidney, all four
phospholipid classes examined showed relatively similar UI level
in all three species. In brain, the UI of PE and PS was high
(compared with PC and PA), primarily due to high
docosahexaenoic acid (22:6n-3) levels and were the major
contributors to the overall UI of the tissue. The major contributor
to the UI in the kidney (in all four phospholipid classes) was
arachidonic acid, in brain it was docosahexaenoic acid,
emphasising the omega-6 and omega-3 dominance of kidney and
brain, respectively.
Body mass variation and phospholipid molecules
As shown in Fig.1 and Fig.2 many of the glycerophospholipids
show body mass trends. In kidney, the major PC molecules,
16:0/18:1 and PC16:0/18:2, both increased with increasing body
J. R. Nealon and others
Table  2. Statistical significance of differences between mouse, sheep and cow in the levels of major glycerophospholipids present in
kidney and brain as presented in Fig. 1 and Fig. 2
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MC
MS
SC
MC
MS
SC
MC
MS
SC
18:1 MC**
MS***
SC**
MC***
MS*
SC*
MC***
MS***
SC
MC**
MS*
SC
MC*
MS
SC*
MC
MS
SC
18:2 MC*
MS
SC
MC***
MS***
SC
MC***
MS**
SC
20:4 MC***
MS***
SC
MC**
MS
SC***
MC*
MS**
SC
MC*
MS**
SC
MC
MS
SC
18:1
22:6 MC**
MS*
SC
MC***
MS***
SC
MC
MS
SC*
MC*
MS
SC
MC
MS
SC
MC
MS
SC
M, mouse; S, sheep; C, cow; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PS, phosphatidylserine.
***P<0.001, **0.001>P<0.01, *0.01>P<0.05, no asterisks indicates not significant at P>0.05.
Phospholipid molecular species that occurred only in one animal species or in one phospholipid class at very low concentration were excluded to
minimize the number of data columns within the table. These phospholipid molecules included 16:0/18:3, 16:0/20:3 and 16:0/22:5 in kidney and
18:0/20:1 plus 18:0/20:2 in brain.
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mass whereas PC16:0/22:6, 16:0/20:4 and
18:0/20:4 each with a long, highly
unsaturated acyl chain tended to decrease
in concentration with increasing body
mass. The reduction in arachidonic acid
(20:4n-6) with increasing body mass in PC
of kidney, however, did not cause a fall in
the overall omega-6 content of the PC
lipids since the shorter-chained, less
unsaturated linoleic acid made up the
difference, with increasing concentrations
of PC16:0/18:2. The main PE and PS
molecules in the kidney also showed some
body mass changes with molecular
combinations, with monounsaturates
(18:1) and linoleic acid (18:2) increasing
(e.g. PE 16:0/18:1, 18:1/18:1, 16:0/18:2
and 18:1/18:2 and PS 16:0/18:2 and
18:0/18:2) with body mass and those
molecules with long, highly unsaturated
acyl chains (20:4 and 22:6) decreasing (e.g.
PE16:0/22:6, 18:0/22:6 and 18:1/22:6 and
PS 16:0/20:4, 18:0/20:4, 18:0/22:6; see
Fig.1 and Table2 for statistical analysis of
phospholipid species). Basically, as
mammals increased in body mass the acyl
chain of the kidney phospholipids became
less unsaturated with fewer phospholipid
molecules containing 22:6 and 20:4 and
more contained 18:1 and 18:2 (Fig. 1;
Table 3). Therefore, reductions in
unsaturation index (UI) were underpinned
by mass-dependent changes in every major
phospholipid class.
In brain, there were fewer differences in
the concentration of phospholipids, with
those containing either arachidonic (20:4)
or docosahexaenoic (22:6) acid being more
similar between the species. There was a
tendency for brain phospholipid molecules
containing 18:1 to increase with body
mass, notably among these was
PC 16:0/18:1. Few brain phospholipid
molecules contained linoleic acid (18:2)
presumably as a result of it being converted
to the longer chained arachidonic acid
(20:4n-6). Few body mass trends seemed
to be apparent in the brain with phospholipids displaying a more
uniformed acyl phospholipid composition among the different-sized
mammals.
DISCUSSION
This study supports the proposal that differences in membrane
phospholipid acyl composition associated with differences in body
mass in mammals are a product of systematic generalised changes
in the composition of the acyl chains across all phospholipid classes.
It shows that differences in membrane phospholipid acyl
composition are not restricted to any particular type of phospholipid
molecule or to any specific phospholipid class. The results agree
with those of another recent study showing the same generalised
differences in acyl composition spread throughout phospholipid
classes in an endothermic mammal (rat) and ectothermic reptile
(lizard) (Mitchell et al., 2007). The results of the study also support
the proposition that membrane phospholipid class distribution is
regulated in tissues irrespective of body size. The distribution of
membrane phospholipid classes within kidney and brain were
essentially the same in the three different-sized mammals. The
combined percentage of phosphatidylcholine (PC) and
phosphatidylethanolamine (PE) was ~91% and ~88% of all
glycerophospholipid molecules in the kidney and brain, respectively,
in the three mammal species. These values are comparable to 88
and 86% of all glycerophospholipid molecules for PC and PE found
in kidney and brain of another mammal and a reptile previously
examined (Mitchell et al., 2007).
Many different types of phospholipid molecules within each class
of phospholipid showed body-mass-related differences in their acyl
composition. These differences account for the previously described
Table3. Kidney fatty acid characterisation showing the distribution of saturated,
monounsaturated, omega-3 and omega-6 polyunsaturated fatty acids plus the contribution to
unsaturation index of the major fatty acids within each phospholipid classes
Phospholipid Mouse Sheep Cow
Phosphatidylcholine 
ΣSFA 54.4±0.9 47.8±4.6 49.5±6.1
ΣMUFA 11.5±0.2s,c 23.1±2.1m 19.8±1.6m
ΣPUFA n-6 26.1±0.8 21.8±2.4 27.6±4.5
ΣPUFA n-3 8.0±0.7c 7.2±1.0 3.1±0.3m
UI 144.7±3.5s,c 122.2±2.4m,c 107.7±1.0m,s
UI (18:1 n-9) 10.6±0.1s,c 21.2±0.5m,c 17.4±1.1m,s
UI (18:2 n-6) 19.2±0.9s,c 24.7±1.6m,c 35.6±3.5m,s
UI (20:4 n-6) 54.9±1.8s,c 21.3±1.8m 18.8±0.8m
UI (22:6 n-3) 47.7±3.1s,c 16.4±2.5m,c 5.0±0.4m,s
Phosphatidylethanolamine 
ΣSFA 37.3±1.6c 35.0±3.9 27.7±1.9m
ΣMUFA 14.9±0.9c 21.9±3.3 27.8±1.5m
ΣPUFA n-6 39.4±1.7 34.2±4.3 38.4±3.4
ΣPUFA n-3 8.4±0.7c 9.1±1.3 6.2±0.5m
UI 215.0±1.5s,c 189.5±2.0m 185.3±1.8m
UI (18:1 n-9) 14.9±0.4s,c 21.4±0.5m,c 26.2±0.9m,s
UI (18:2 n-6) 9.2±0.4s,c 18.0±1.5m,c 28.0±1.5m,s
UI (20:4 n-6) 125.7±0.4s,c 92.4±3.9m 90.7±1.3m
UI (22:6 n-3) 50.4±1.6s,c 21.1±1.0m,c 9.4±1.8m,s
Phosphatidylserine 
ΣSFA 48.3±2.2 42.4±4.3 39.5±3.2
ΣMUFA 9.8±0.4s,c 25.1±2.8m 21.9±2.3m
ΣPUFA n-6 36.5±1.6 28.2±3.4 37.1±2.8
ΣPUFA n-3 5.4±0.5c 4.2±1.0 1.5±0.4m
UI 183.0±1.4s,c 146.4±3.1m,c 134.2±4.1m,s
UI (18:1 n-9) 9.9±0.3s,c 24.7±0.3m 20.1±1.2m
UI (18:2 n-6) 5.9±0.3s,c 14.0±0.4m,c 43.7±1.2m,s
UI (20:4 n-6) 118.2±2.0s,c 75.4±1.5m,c 34.2±2.4m,s
UI (22:6 n-3) 28.3±0.05s,c 10.9±1.8m,c 2.4±0.8m,s
Phosphatidic acid 
ΣSFA 34.6±4.6 34.4±3.4 28.8±9.1
ΣMUFA 13.1±2.2s 35.1±3.5m 35.9±8.5
ΣPUFA n-6 48.7±6.2s 24.7±4.7m 33.0±7.9
ΣPUFA n-3 4.2±0.5c 5.8±1.5 2.3±0.6m
UI 181.0±0.6s,c 143.1±10.1m 133.8±5.4m
UI (18:1 n-9) 12.6±0.6s,c 35.4±1.6m 36.8±1.8m
UI (18:2 n-6) 44.7±0.9s,c 11.2±2.1m,c 26.5±5.5m,s
UI (20:4 n-6) 86.3±1.3c 74.7±10.7c 31.1±0.8m,s
UI (22:6 n-3) 18.7±1.3s,c 0.0±0.0m 0.0±0.0m
SFA, saturated fatty acid ; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid; Σ, total,
Ul, unsaturation index (the number double bonds per 100 fatty acid molecules).
Superscript letters indicate significant differences between the values derived for mouse (m), sheep (s)
and cow (c) at a minimum of P<0.05. n-3, n-6, n-9 denote the location of the first double bond from the
methyl end of the molecule. Values are mean ± s.e.m. (N=4).
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decrease in membrane unsaturation associated with increasing body
mass in mammalian species measured using gas chromatography
(Hulbert et al., 2002b). This body-mass-dependent decrease in
membrane unsaturation does not occur by decreases in the
percentage of unsaturated acyl chains but alternatively by alterations
in the type of unsaturates present. This includes increases in the use
of monounsaturates (MUFA) and shorter, less unsaturated molecules
at the expense of long-chain omega-3 (n-3) and omega-6 (n-6)
polyunsaturated (PUFA) fats. This substitution was clearly evident
in the kidney, with an increase in MUFA and a decrease in the long-
chained, highly unsaturated omega-3 and omega-6 PUFAs with
increasing body mass. In brain, the mass-dependent differences in
phospholipid acyl composition were far less pronounced (as
indicated by the reduction in the number of significant differences
between the mammals) than in the kidney (see Table2), in agreement
with the previous work of Hulbert and
colleagues (Hulbert et al., 2002b).
The domination of omega-6 in kidney
and omega-3 in brain was found to be
spread throughout the phospholipid classes
and was not restricted to any one particular
phospholipid class. In kidney all the PC
molecules showed high omega-6 PUFA
content as a percentage of their overall fatty
acid composition (PC; 26–28%, PE;
34–39%, PS; 28–37%, PA; 25–48%).
However, the makeup of these omega-6
fats in kidney moved from primarily
arachidonic acid to linoleic acid in PC, PE
and PS with increasing body mass. The
single largest contributor to the arachidonic
acid content of kidney membranes was PE
18:0/20:4, followed by PC 16:0/20:4,
whereas the major contributor to linoleic
acid was PC16:0/18:2 (see Fig.1). In the
brain, the omega-3 domination of PUFA
was also found spread throughout all
phospholipid classes except PC, which had
slightly more omega-6 than omega-3 in all
three mammals measured. In brain the
dominant omega-3 acyl chain was the
long-chained docosahexaenoic acid (22:6n-
3) with both PE18:0/22:6 and PS18:0/22:6
being the major contributors (64–79%).
The brain also displayed less diversity of
phospholipid molecules (64–66) compared
with the kidney (82–120; including all PC,
PE, PS, PA, PG and SM molecules). This
greater phospholipid molecular diversity in
the kidney was also found in an analysis
of tissues of an ectothermic lizard (Mitchell
et al., 2007).
The measurement of the fatty acid
acyl composition of kidney and brain
membrane glycerophospholipids by gas
chromatography (GC) and mass
spectrometry (MS) showed some clear
differences. These differences included
higher estimations for 16:0 and a lower
estimation for 20:4n-6 and sometimes
22:6n-3 using MS than using GC (Table5).
These differences were also found in a
previous study (Mitchell et al., 2007) and points to the trend for a
lower estimation of unsaturation index using MS versus GC (in the
kidney) primarily due to the effect of 20:4n-6 and 22:6n-6 upon UI.
The present study also found a lack of sphingomyelin
phospholipids in both the kidney and brain of the mouse, a
condition not apparent in tissues of the large mammal species.
In sheep and cow, nine different types of sphingomyelin molecules
were detected in the kidney and five in the brain, with the major
molecules in both tissues being SM16:0 and SM18:0, respectively.
Since lipid rafts/caveolae structures are primarily composed of
sphingomyelin and cholesterol (Simons and Vaz, 2004; Slotte and
Ramstedt, 2007) and the cholesterol to phospholipid ratio is
similar in different-sized mammals (Starke-Peterkovic et al.,
2005) it seems likely that the composition of these lipid structures
varies with body mass, with the cholesterol to sphingomyelin ratio
J. R. Nealon and others
Table4. Brain fatty acid characterisation showing the distribution of saturated,
monounsaturated, omega-3 and omega-6 polyunsaturated fatty acids plus the contribution to
unsaturation index of the major fatty acids within each phospholipid classes
Phospholipid Mouse Sheep Cow
Phosphatidylcholine 
ΣSFA 61.9±3.9 58.4±0.9 57.4±2.2
ΣMUFA 27.5±2.0 33.9±1.1 36.2±3.2
ΣPUFA n-6 6.2±0.4s,c 4.1±0.2m 3.8±0.2m
ΣPUFA n-3 4.5±0.4c 3.6±0.2 2.6±0.6m
UI 78.7±1.3s,c 70.7±0.7m 67.3±2.6m
UI (18:1 n-9) 25.2±0.2s,c 29.9±0.5m 32.3±1.5m
UI (18:2 n-6) 0.5±0.1s,c 1.1±0.1m,c 1.5±0.1m,s
UI (20:4 n-6) 22.5±1.1s,c 13.7±1.0m 11.3±1.3m
UI (22:6 n-3) 27.1±0.6s 21.4±1.2m 16.3±3.5
Phosphatidylethanolamine 
ΣSFA 45.2±7.7 45.1±4.6 43.4±4.4
ΣMUFA 11.4±1.8 11.7±1.0 16.7±2.8
ΣPUFA n-6 13.4±2.9 12.7±1.7 13.4±1.3
ΣPUFA n-3 30.0±4.2 30.6±2.9 26.5±4.2
UI 246.1±1.8 247.1±1.1 230.0±7.9
UI (18:1 n-9) 11.0±0.3 11.5±0.2 16.0±2.2
UI (18:2 n-6) 0±0 0±0 0±0
UI (20:4 n-6) 41.9±1.9s 34.1±2.1m 34.7±3.2
UI (22:6 n-3) 187.0±3.9 184.6±4.4 158.0±13.6
Phosphatidylserine 
ΣSFA 45.2±7.9 47.2±6.2 46.5±3.8
ΣMUFA 18.8±7.6 19.4±5.2 26.2±5.6
ΣPUFA n-6 5.0±1.4 5.1±0.6 5.5±0.7
ΣPUFA n-3 31.1±2.8 28.4±1.6 21.8±2.7
UI 230.9±12.0 211.3±11.6 178.2±19.7
UI (18:1 n-9) 16.9±3.2 17.5±2.3 24.1±3.8
UI (18:2 n-6) 0±0 0±0 0±0
UI (20:4 n-6) 16.1±0.9c 13.5±1.8 12.1±1.3m
UI (22:6 n-3) 196.0±11.2 175.3±13.3 135.0±24.0
Phosphatidic acid 
ΣSFA 43.6±2.5 37.9±3.8 44.9±6.4
ΣMUFA 27.2±2.7 42.5±9.9 40.2±8.7
ΣPUFA n-6 7.0±1.3 6.1±0.8 2.8±0.7
ΣPUFA n-3 22.2±0.7 13.6±1.9 12.0±2.4
UI 188.7±2.2 150.9±10.9 130.3±19.9
UI (18:1 n-9) 27.0±1.0 41.1±4.4 39.0±4.4
UI (18:2 n-6) 0±0 0±0 0±0
UI (20:4 n-6) 27.5±3.3c 26.3±5.8 10.7±1.4m
UI (22:6 n-3) 134.2±5.9 83.4±10.8 80.6±24.4
SFA, saturated fatty acid ; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid; Σ,
total; UI, unsaturation index (the number double bonds per 100 fatty acid molecules).
Superscript letters indicate significant differences between the values derived for mouse (m), sheep (s)
and cow (c) at a minimum P<0.05. n-3, n-6, n-9 denote the location of the first double bond from the
methyl end of the molecule. Values are mean ± s.e.m. (N=4).
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decreasing with increasing body mass in mammals.
Sphingomyelin molecules, however, have been reported to be
present in other mouse tissues, including mouse lens tissues, at
up to 20% of total phospholipids [(Iwata et al., 1995); although
lens tissue is known to have an extraordinarily high level of this
particular phospholipid (Slotte and Ramstedt, 2007)]. These
results suggest that the tissues of larger mammals may possess
higher concentration or bigger raft structures. The potential
functional implications of this finding and the involvement of
these structures in modulating metabolism also remains an
interesting unexplored possibility.
The primary idea of the membrane pacemaker theory is that
membrane lipids provide an environment that can increase or
decrease the activity of intrinsic proteins. The activity of membrane
bound enzymes, such as Na+/K+-ATPase, is very different in
mammals of different body mass. In the mouse, Na+/K+-ATPase
molecular activities (turnover rate per enzyme) in the kidney and
brain has been calculated at 23,000 and 28,800 ATP min–1,
respectively (Turner et al., 2005a; Turner et al., 2005b). In the
cow the molecular activities of the Na+/K+-ATPase in kidney and
brain is much lower at 6300 and 11,400 ATP min–1, respectively
(Starke-Peterkovic et al., 2005). These large differences in
molecular activity have been linked to differences in the acyl
composition of the membrane phospholipids including the level
of membrane unsaturation and presence of long-chain highly
polyunsaturated fats, especially DHA (Turner et al., 2003). The
results of the present study suggest no single type of phospholipid
molecule or phospholipid class will be responsible for determining
the membrane properties associated with acyl composition between
species since the difference is spread across the full range of
phospholipids.
Na+/K+-ATPase molecular activity has also been shown to
correlate more strongly with the lateral pressure of membrane lipid
mixtures than with the composition of any individual fatty acid in
the membrane (Wu et al., 2001). Na+/K+-ATPase appears to be
distributed primarily in non-raft domains of the cell membrane
(Atshaves et al., 2003; Gallegos et al., 2006) and is influenced by
the transbilayer fluidity gradient (Schroeder et al., 2005; Schroeder
and Sweet, 1988; Sweet and Schroeder, 1986a; Sweet and Schroeder,
1986b; Sweet and Schroeder, 1988). This suggests that differences
in molecular activity are likely to be influenced by the physical
properties of the bulk phase membrane lipids created by the acyl
composition of the phospholipids. This may be explained by the
fact that highly polyunsaturated fats have high level of dynamic
motion and flexibility since they have more bisallylic bonds (those
that occur on either side of the multiple double bonds present in
highly polyunsaturated molecules). This can create high lateral
pressures in the immediate environment of these acyl chains that
may impinge upon the properties of neighbouring proteins and other
lipids in the membrane (Carrillo-Tripp and Feller, 2005). In this
Table5. A comparison of the percentage of major fatty acids in kidney and brain of mouse, sheep and cow, as measured by gas
chromatography and mass spectrometry 
Mouse Sheep Cow
Phospholipid GC MS GC MS GC MS
Kidney 
16:0 12.9±0.2* 34.5±0.4s 18.5±0.6* 25.9±0.4m,c 20.7±0.5* 33.4±0.9s
18:0 15.8±0.4 15.6±0.2s,c 16.8±0.4 18.2±0.1m,c 12.9±0.2* 8.8±0.5m,s
18:1 7.8±0.1* 11.7±0.2s,c 16.0±0.9* 22.0±0.4m 15.7±0.3 17.8±1.1m
18:2n-6 9.5±0.3 8.6±0.4c 10.1±0.7 11.2±0.7c 15.6±2.4 17.5±1.3m,s
20:4n-6 23.3±0.5* 18.3±0.3s,c 13.4±0.7* 9.8±0.5m 13.1±0.4* 9.1±0.3m
22:5n-6 1.1±0.3 1.6±0.1s,c – 3.0±0.2m – 2.6±0.2m
22:6n-3 16.6±0.6* 7.8±0.4s,c 3.1±0.2 2.7±0.3m,c 1.3±0.1 1.0±0.1m,s
UI 249±4* 161±3s,c 172±3* 136±2m,c 163±5* 128±1m,s
Σn-6 36.5±0.6* 28.3±0.2s 24.2±1.1 21.6±0.4m,c 30.6±0.6 27.9±1.1s
Σn-3 17.7±0.7* 9.4±0.4c 14.1±0.5* 10.1±0.6c 10.0±2.4 6.4±0.6m,s
ΣUNSAT 71.0±0.6* 49.8±0.3s,c 63.4±0.5* 55.1±0.4m,c 65.3±0.5* 56.7±0.5m,s
ΣMUFA 16.5±0.2* 12.2±0.2s,c 24.4±0.8 23.4±0.4m 24.3±0.8 22.4±1.2m
ΣPUFA 54.6±0.8* 37.6±0.4s,c 39.0±1.1* 31.6±0.5m,c 41.1±1.0* 34.2±0.7m,s
Brain 
16:0 21.9±1.6* 36.5±1.0 17.2±0.7* 35.9±0.6 17.4±1.1* 34.5±0.7
18:0 15.8±0.8* 19.5±0.6 13.0±0.3* 18.0±0.6 14.0±0.8* 18.0±0.4
18:1 20.2±0.5 21.6±0.6c 21.4±1.0* 25.5±0.5 26.8±2.4 28.4±2.0m
20:4n-6 10.5±0.7* 6.4±0.4s,c 7.3±0.6* 4.2±0.4m 6.7±0.5* 3.6±0.3m
22:6n-3 17.7±2.1 13.0±0.4c 21.0±1.2* 11.3±0.1 14.7±2.7 9.1±1.3m
UI 196±15 144±5  218±7* 138±3  182±13 128±4
Σn-6 14.7±1.0* 7.6±0.5s,c 12.7±0.8* 5.8±0.4m 12.1±0.5* 5.6±0.4m
Σn-3 18.2±1.9 13.0±0.4c 22.8±1.1* 11.4±0.1 16.1±2.6 9.1±1.3m
ΣUNSAT 62.2±2.1* 43.7±0.5c 68.1±0.9* 45.6±0.4 68.3±1.8* 46.6±0.9m
ΣMUFA 29.2±1.0* 23.1±0.6s,c 32.0±1.3 28.4±0.8m 39.5±3.4 31.8±2.1m
ΣPUFA 33.0±3.0 20.6±1.0s,c 36.1±1.5* 17.2±0.5m 28.8±2.7* 14.8±1.3m
MS, mass spectrometry; GC, gas chromatography [data from Hulbert et al. (Hulbert et al., 2002b)]. For the purpose of calculating Σn-6 and Σn-3 values the
minor contributions of 20:3 were designated as predominantly omega-6 and those for 20:5 and 22:5 as omega-3 in kidney and 22:5 designated as
predominantly omega-6 in brain based on the results of Hulbert et al. ΣUNSAT, total of unsaturated fatty acids; ΣMUFA, total monounsaturated fatty acids;
ΣPUFA, total polyunsaturated fatty acids; Σn-6 and Σn-3, total polyunsaturated omega-6 and omega-3 fatty acids, respectively; UI, unsaturation index (the
number double bonds per 100 fatty acid molecules). 
Values are mean percentage ± s.e.m. (N=4). Superscript letters in the MS columns indicate significant difference between the values derived for mouse (m),
sheep (s) and cow (c) at a minimum of P<0.05 whereas in the GC column the asterisk indicates a significant difference (P<0.05) between measurements
made by GC [in the study of Hulbert et al. (Hulbert et al., 2002b)] and to those made by MS (the present study).
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case, the present study suggests that all classes of phospholipids are
likely to be involved in determining the physical properties of the
membrane and any associated change in metabolism.
In summary, this study shows that differences in membrane
phospholipid acyl composition associated with body mass in
mammals are spread throughout the different classes of
phospholipids, and that phospholipid class distribution is very similar
in the same tissues of the different-sized mammals and is likely to
be a regulated property of membranes in vertebrates. Furthermore,
given that these same properties were found in a similar comparison
in a different mammal (rat) and an ectothermic vertebrate (lizard)
(Mitchell et al., 2007) it suggests that the physical properties of
membranes may be an important determinant of the rate of
metabolism in animal species.
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1Table S1. Mass spectrometry scan parameters
Scan type Ion mode Fragment Collision energzy (eV)
Head-group scans
PC and SM Precursor ion Positive m/z 184.1 35
PE Neutral loss Positive 141.5 Da 25
PS Neutral loss Positive 185.4 Da 22
PA and PG Precursor ion Negative m/z 153.0 50
Fatty acyl chain scans
14:0 Precursor Ion Negative m/z 227.4 50
Neutral loss Positive (lithiated) 287.4 Da 35
15:0 Precursor ion Negative m/z 241.4 50
Neutral loss Positive (lithiated) 301.4 Da 35
16:0 Precursor ion Negative m/z 255.4 50
Neutral loss Positive (lithiated) 315.4 Da 35
16:1 Precursor ion Negative m/z 253.4 50
Neutral loss Positive (lithiated) 313.4 Da 35
17:0 Precursor ion Negative m/z 269.4 50
Neutral loss Positive (lithiated) 329.4 Da 35
18:0 Precursor ion Negative m/z 283.4 50
Neutral loss Positive (lithiated) 343.4 Da 35
18:1 Precursor ion Negative m/z 281.4 50
Neutral loss Positive (lithiated) 341.4 Da 35
18:2 Precursor ion Negative m/z 279.4 50
Neutral loss Positive (lithiated) 339.4 Da 35
18:3 Precursor ion Negative m/z 277.4 50
Neutral loss Positive (lithiated) 337.4 Da 35
20:1 Precursor ion Negative m/z 309.4 50
Neutral loss Positive (lithiated) 369.4 Da 35
20:2 Precursor ion Negative m/z 307.4 50
Neutral loss Positive (lithiated) 367.4 Da 35
20:3 Precursor ion Negative m/z 305.4 35
Neutral loss Positive (lithiated) 365.4 Da 35
20:4 Precursor ion Negative m/z 303.4 35
Neutral loss Positive (lithiated) 363.4 Da 35
20:5 Precursor ion Negative m/z 301.4 35
Neutral loss Positive (lithiated) 361.4 Da 35
22:4 Precursor ion Negative m/z 331.4 35
Neutral loss Positive (lithiated) 391.4 Da 35
22:5 Precursor ion Negative m/z 329.4 35
Neutral loss Positive (lithiated) 389.4 Da 35
22:6 Precursor ion Negative m/z 327.4 35
Neutral loss Positive (lithiated) 387.4 Da 35
PC, phosphatidylcholine; SM, sphingomyelin; PE, phosphatidylethanolamine; PS, phosphatidylserine;
PA, phosphatidic acid; PG, phosphatidylglycerol; PI, phosphatidylinositol.
m/z, mass-to-charge ratio.
